AusPAR: Eribulin mesilate

Australian Public Assessment Report

AusPAR

AusPAR: Eribulin mesilate [PDF, 926.83 KB]

Attachment: Product Information: Eribulin mesilate [PDF, 224.32 KB]

Attachment: Product Information: Eribulin mesilate [Word, 112.61 KB]

Attachment: Extract from Clinical Evaluation Report: Eribulin mesilate [PDF, 2.08 MB]

AusPAR: Eribulin mesilate [Word, 1.24 MB]

Attachment: Extract from Clinical Evaluation Report: Eribulin mesilate [Word, 3.67 MB]

Device/Product Name

Halaven

Active ingredients

Eribulin mesilate

AusPAR Date

17 May 2013

Published

4 July 2013

Submission Number

PM-2011-01624-3-4

Submission Type

New chemical entity

Decision

Approved